102 related articles for article (PubMed ID: 8614366)
41. Assessment of osteosarcoma response to preoperative chemotherapy using dynamic FLASH gadolinium-DTPA-enhanced magnetic resonance mapping.
Hanna SL; Parham DM; Fairclough DL; Meyer WH; Le AH; Fletcher BD
Invest Radiol; 1992 May; 27(5):367-73. PubMed ID: 1582820
[TBL] [Abstract][Full Text] [Related]
42. Treatment of osteosarcoma.
Waters KD
Clin Exp Pharmacol Physiol Suppl; 1979; 5():11-6. PubMed ID: 318496
[TBL] [Abstract][Full Text] [Related]
43. Effect of chemotherapy on human growth plate.
Bar-On E; Beckwith JB; Odom LF; Eilert RE
J Pediatr Orthop; 1993; 13(2):220-4. PubMed ID: 8459015
[TBL] [Abstract][Full Text] [Related]
44. Automated pixel-by-pixel mapping of dynamic contrast-enhanced MR images for evaluation of osteosarcoma response to chemotherapy: preliminary results.
Hanna SL; Reddick WE; Parham DM; Gronemeyer SA; Taylor JS; Fletcher BD
J Magn Reson Imaging; 1993; 3(6):849-53. PubMed ID: 8280973
[TBL] [Abstract][Full Text] [Related]
45. Osteosarcoma: chemotherapy-induced changes at MR imaging.
Holscher HC; Bloem JL; Vanel D; Hermans J; Nooy MA; Taminiau AH; Henry-Amar M
Radiology; 1992 Mar; 182(3):839-44. PubMed ID: 1535905
[TBL] [Abstract][Full Text] [Related]
46. Preoperative evaluation and monitoring chemotherapy in patients with high-grade osteogenic and Ewing's sarcoma: review of current imaging modalities.
van der Woude HJ; Bloem JL; Hogendoorn PC
Skeletal Radiol; 1998 Feb; 27(2):57-71. PubMed ID: 9526770
[TBL] [Abstract][Full Text] [Related]
47. Response of osteosarcoma and Ewing sarcoma to chemotherapy: imaging evaluation.
Fletcher BD
AJR Am J Roentgenol; 1991 Oct; 157(4):825-33. PubMed ID: 1892044
[TBL] [Abstract][Full Text] [Related]
48. Response of osteosarcoma and Ewing sarcoma to preoperative chemotherapy: assessment with dynamic and static MR imaging and skeletal scintigraphy.
Shapeero LG; Henry-Amar M; Vanel D
Invest Radiol; 1992 Nov; 27(11):989-91. PubMed ID: 1464523
[No Abstract] [Full Text] [Related]
49. MR imaging of osteogenic and Ewing's sarcoma.
Boyko OB; Cory DA; Cohen MD; Provisor A; Mirkin D; DeRosa GP
AJR Am J Roentgenol; 1987 Feb; 148(2):317-22. PubMed ID: 3492110
[TBL] [Abstract][Full Text] [Related]
50. [Apropos of 40 cases of malignant tumors treated by local-regional and general chemotherapy in a surgical department].
Banzet P; De la Caffinière JY; Dufourmentel C
J Chir (Paris); 1969 Mar; 97(3):321-30. PubMed ID: 5269098
[No Abstract] [Full Text] [Related]
51. Ewing sarcoma: MR imaging of chemotherapy-induced changes with histologic correlation.
MacVicar AD; Olliff JF; Pringle J; Pinkerton CR; Husband JE
Radiology; 1992 Sep; 184(3):859-64. PubMed ID: 1509080
[TBL] [Abstract][Full Text] [Related]
52. Percent slope analysis of dynamic magnetic resonance imaging for assessment of chemotherapy response of osteosarcoma or Ewing sarcoma: systematic review and meta-analysis.
Kubo T; Furuta T; Johan MP; Adachi N; Ochi M
Skeletal Radiol; 2016 Sep; 45(9):1235-42. PubMed ID: 27229874
[TBL] [Abstract][Full Text] [Related]
53. The use of gadolinium in the MR imaging of bone tumors.
Sundaram M
Semin Ultrasound CT MR; 1997 Aug; 18(4):307-11. PubMed ID: 9285999
[TBL] [Abstract][Full Text] [Related]
54. Monitoring the effect of chemotherapy in Ewing's sarcoma of bone with MR imaging.
van der Woude HJ; Bloem JL; Holscher HC; Nooy MA; Taminiau AH; Hermans J; Falke TH; Hogendoorn PC
Skeletal Radiol; 1994 Oct; 23(7):493-500. PubMed ID: 7824974
[TBL] [Abstract][Full Text] [Related]
55. Assessment of osteosarcoma response to neoadjuvant chemotherapy: comparative usefulness of dynamic gadolinium-enhanced spin-echo magnetic resonance imaging and technetium-99m skeletal angioscintigraphy.
Ongolo-Zogo P; Thiesse P; Sau J; Desuzinges C; Blay JY; Bonmartin A; Bochu M; Philip T
Eur Radiol; 1999; 9(5):907-14. PubMed ID: 10369989
[TBL] [Abstract][Full Text] [Related]
56. Color Doppler ultrasonography evaluation for chemotherapy treatment response of osteogenic sarcoma.
Lin YH; Chiou HJ; Chen WM; Yen CC; Chou YH; Hung GY; Chang CY
Ultrasound Med Biol; 2012 Feb; 38(2):202-8. PubMed ID: 22230132
[TBL] [Abstract][Full Text] [Related]
57. [31-phosphorus spectroscopy of osteogenic sarcoma. Possibilities in therapy control in comparison with imaging methods].
Just M; Gutjahr P; Juretschke HP; Dittrich M; Higer HP; Klose KJ; Ritter G
Rofo; 1987 Feb; 146(2):144-8. PubMed ID: 3029826
[TBL] [Abstract][Full Text] [Related]
58. Can MRI predict the histopathological response in patients with osteosarcoma after the first cycle of chemotherapy?
Holscher HC; Bloem JL; van der Woude HJ; Hermans J; Nooy MA; Taminiau AH; Hogendoorn PC
Clin Radiol; 1995 Jun; 50(6):384-90. PubMed ID: 7789022
[TBL] [Abstract][Full Text] [Related]
59. Changes in tumor perfusion induced by chemotherapy in bone sarcomas: color Doppler flow imaging compared with contrast-enhanced MR imaging and three-phase bone scintigraphy.
van der Woude HJ; Bloem JL; Schipper J; Hermans J; van Eck-Smit BL; van Oostayen J; Nooy MA; Taminiau AH; Holscher HC; Hogendoorn PC
Radiology; 1994 May; 191(2):421-31. PubMed ID: 8153316
[TBL] [Abstract][Full Text] [Related]
60. Initial symptoms and clinical features in osteosarcoma and Ewing sarcoma.
Widhe B; Widhe T
J Bone Joint Surg Am; 2000 May; 82(5):667-74. PubMed ID: 10819277
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
